About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,497 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,497 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3641-3660 of 7,497 trials

TerminatedDoxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone MetastasesRATIONALE: Drugs used in chemotherapy, such as doxorubicin, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00080782·Houston, Texas Active not recruitingIntraprostatic Anesthesia During Transperineal Prostate BiopsyTransperineal prostate biopsy has become the standard method for diagnosing prostate cancer because of its favorable safety profile and low infectious complication rates.NCT07683182·Istanbul, Pendik

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

CompletedEuropean Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-upThis is an open observational extended follow-up study of patients originally randomized into TOOKAD® Soluble VTP therapy or active surveillance (control group).NCT04017325·Tampere and 35 others

RecruitingFeasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)The accuracy of radiotherapy can be increased by correcting for geometric uncertainties and changes between radiotherapy fractions.NCT06691776·Amsterdam

CompletedSafety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically AdministeredThe purpose of this study is to evaluate pharmacokinetics, safety and tolerability profile of BZ371A topically administered in healthy patients.NCT05332340·Valinhos, São Paulo

TerminatedPSMA-PET/MRI Unfavorable-Risk Target Volume Pilot StudyThe goal of this study is to investigate the feasibility and toxicity of using prostate-specific membrane antigen-positron emission tomography (PSMA-PET) and multi-parametric…NCT04176497·Chapel Hill, North Carolina

CompletedA Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate CancerPilot study to evaluate the ability of BR55 to identify prostate cancer lesions with Gleason Score ≥7 by ultrasound molecular imaging on the basis of a visual score in comparison…NCT02142608·Stanford, California and 1 other

CompletedSafety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate CancerThe purpose of this study is to determine the safety and effectiveness of the combination of docetaxel and ZD1839 on destroying prostate cancer before removal of the prostate.NCT00242918·Seattle, Washington

CompletedRadium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate CancerStudy of Radium Ra 223 dichloride with enzalutamide compared to enzalutamide alone in men with metastatic castration refractory prostate cancerNCT02199197·Salt Lake City, Utah

CompletedChange in Penile Length Following Bilateral Nerve-Sparing Radical ProstatectomySome men complain of changes in the shape or dimensions of their penis after undergoing radical prostatectomy (removal of the prostate) for prostate cancer.NCT00800813·New York, New York

RecruitingPOSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 LesionsThe goal of this study to determine if using the (18)F-rhPSMA-7.3 PET-CT scan can improve the ability to spot serious prostate cancer in patients who have uncertain MRI results.NCT07220720·Jacksonville, Florida

CompletedStrength, Aging, and Memory in Prostate CancerThe objective of this study is to compare changes in neurocognitive function across a 12-month period between three groups: (1) men treated with androgen deprivation therapy (ADT)…NCT04852224·Omaha, Nebraska

CompletedA Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy SubjectsThe study was designed to evaluate the pharmacokinetic effects of Rifampicin on HRS-5041 after oral administration of HRS-5041 tablets in healthy subjects.NCT07014488·Jinan, Shandong

CompletedEfficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate CancerThis open-label, multicenter, Phase 2 trial, will assess the anti tumor activity, safety and pharmacokinetics, of Panzem® NCD in patients with metastatic, docetaxel refractory…NCT00394810·Indianapolis, Indiana and 3 others

CompletedImproving Urinary Continence and Quality of Life in Prostate Cancer PatientsThis intervention program combines biofeedback PFME with a telephone or support group intervention to treat persistent urinary incontinence (UI).NCT01365182

TerminatedA Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate BiopsyProstate cancer is the most common cancer and the second-leading cause of cancer death amongst men in the United States.NCT01748890·Boston, Massachusetts

CompletedCasodex/Zoladex Biomarkers in Localised Prostate CancerTo evaluate anti-androgen (bicalutamide) induced biological and molecular changes in prostate comparison to chemical castration induced (goserelin) onesNCT00293696·Tampere

Active not recruitingNivolumab in Patients With High-Risk Biochemically Recurrent Prostate CancerThis research study is studying an immune-based cancer drug as a possible treatment for prostate cancer. The drug involved in this study is: -NivolumabNCT03637543·Boston, Massachusetts and 4 others

CompletedGallium-68 Citrate PET Used in Prostate CancerThis is a single center, pilot, cross-sectional imaging study investigating the use of gallium-68 citrate PET in participants with metastatic castration-resistant prostate cancer…NCT02391025·San Francisco, California

RecruitingPSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate CancerProstate cancer (PCa) is the most common non-skin malignancy and the third leading cause of cancer death in North American men.NCT03594760·Montreal, Quebec

PreviousPage 183 of 375Next